
Sign up to save your podcasts
Or
In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
5
3232 ratings
In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
227 Listeners
25,714 Listeners
111,073 Listeners
55,861 Listeners
9,211 Listeners
15,949 Listeners
185 Listeners
386 Listeners
570 Listeners
5,969 Listeners
21 Listeners
700 Listeners
7 Listeners
2 Listeners
6 Listeners